Patrick J. Murphy
Sunwin Stevia International, Inc. is engaged in the production and sale of zero calorie, all natural sweeteners (Sunwin Stevia™ Extracts). With operations based in China, Sunwin has built an integrated global firm with the sourcing and production capabilities to meet the needs of consumers throughout the world. The Company’s operations are organized into two segments – Stevioside, sold globally, and Chinese Medicine products, sold within the PRC. Recognizing a global opportunity for all natural sweeteners, Sunwin is working with major international distributors in the U.S., EU and Asia Pacific including WILD Flavors and Domino Foods to develop and distribute stevia related products.
|Select Stock Trading Data|
|Recent Stock Price:||$0.23|
|Shares Outstanding:||167 million|
|Recent Market Cap:||$38.4 million|
|52 Week Range:||$0.13 - $0.40|
|Data sourced from Yahoo! Finance; otcbb.com; Company filings|
The opportunity in the stevia market is driven by multiple trends including not only changing food preferences, but also medical needs, particularly for weight loss.
- The Organic Movement: According to the Organic Trade Association (OTA), the US organic food and beverage market reached $29 billion, a 168% compound annual growth rate since 2000, but still representing only 4% of $673 million total food sales in the U.S. in 2010. This trend is illustrated in the captured in the OTA’s annual survey on the attitudes of U.S. consumers in which 78% of families reported purchasing organic food, 40% of families reported buying more organic food than the year before, and 72% reported being familiar with the USDA’s Organic seal.
- The Rise in Obesity and Prevalence of Diabetes: According the American Diabetes Association, approximately 26 million people in the U.S. have diabetes, representing 8.3% of the population, with 1.9 million new cases in 2010. The high prevalence of diabetes is not surprising in light of the data from the Centers for Disease Control (CDC), which reports that during the past 20 years, there has been a dramatic increase in obesity in the United States and rates remain high at nearly 36% of U.S. adults and approximately 17% of children and adolescents aged 2—19.
- Metabolic Syndrome Affects nearly 50 Million in U. S. Alone: As addressed by the National Institute of Health – “Metabolic syndrome is a name for a group of risk factors that occur together and increase the risk for coronary artery disease, stroke, and type 2 diabetes. Metabolic syndrome is becoming more and more common in the United States. Researchers are not sure whether the syndrome is due to one single cause, but all of the risks for the syndrome are related to obesity.”
- GLG Life Tech Corporation (TSX:GLG.TO): On 11/14/12, GLG, whose business is the agricultural and commercial development of high quality stevia and all natural and zero calorie food and beverage products, reported $5.8 million in quarterly sales, a substantial increase over the prior year’s quarter although revenue for the 9 month period was down 45% relative to 2011.
- Global Stevia Corp. (OTC: GSTV): GSTV is a development stage company focused maximizing the efficient production of stevia leaf. GSTV plans to expand operations by investing in the development of larger test plantations and the acquisition of large parcels of land to have a commercially grown, fully mechanized stevia plantation. Concurrently, GSTV plans to build out propagation labs to propagate and develop stevia varieties and cuttings. Through the period ended 8/31/12, GSTV had not reported revenue and the Company does not expect revenue in the upcoming year.
- Stevia Corp (OTC: STEV): STEV is a development stage company with plans to generate revenues by providing farm management services, the sale of inputs to stevia growers, the sale of stevia on its own farmed property, and the sale of stevia related products. STEV has reported that the Company expects significant revenue in 2013 subject to obtaining capital.
- Stevia First Corporation (OTC: STVF): STVF is engaged in the cultivation and harvest of stevia leaf and the development of stevia products. Through 9/30/12, the Company had not reported revenue.
- Stevia Nutra Corp. (OTC: STNT): STNT, focused on stevia agronomics including plant breeding, proprietary agricultural practices and post-harvest techniques. Through its fiscal year end, 7/31/12, STNT had not reported revenue.
- Sunwin Stevia International (OTC: SUWN): For the quarter ended 7/31/,12, SUNW reported revenue of $3.2 million, approximately 77% of which was from the sale of stevia related products with the balance coming from the sale of Chinese medicines. Stevia revenue increased approximately 19% over the preceding year. For the 12 months ended 7/31/12, SUWN quarterly revenue ranged from $2.9 million to $3.6 million.
Patrick Murphy Bio:
Patrick J. Murphy is the owner of Murphy Analytics LLC, a provider of sponsored research coverage on smallcap stocks. Mr. Murphy has nearly 20 years of capital markets experience providing institutional investment and transaction analysis across a range of asset classes including microcap equities, commercial real estate debt and equity, municipal derivatives and public finance, venture capital, fixed income, CMBS and mortgage REIT's. In addition to his work with Murphy Analytics, Mr. Murphy also serves as a consultant to a municipal derivatives advisory firm. Mr. Murphy is an alumnus of the University of Notre Dame (1991), with an undergraduate degree in Economics, and earned a Masters Degree in Finance from St. Louis University in 1997. Mr. Murphy is a CFA Charterholder and a member of the CFA Society of St. Louis.
Patrick Murphy Disclaimer:
Readers are advised that the above article is solely for information purposes and should not to be construed as an offer to sell or the solicitation of an offer to buy any security. The views expressed herein are based upon the author’s analysis of the issuer's public disclosures, and assumes both their accuracy and completeness. The opinions and statements included herein are based on sources (including the companies discussed and public sources) believed to be reliable and in good faith, but no representation or warranty, express or implied, is made as to their accuracy, completeness or correctness. The author has not independently verified the information contained herein. This information is not intended to be used as the sole basis of any investment decisions, nor should it be construed as advice designed to meet the investment needs of any particular investor. You should review a complete information package on all companies, which should include, but not be limited to, the Company's annual report, quarterly reports, press releases and all regulatory filings. The foregoing discussion contains statements which are based on current expectations, estimates and projections, and differences from such expectations, estimates and projections can be expected. The author, Patrick Murphy, was compensated $500 by InvestorIdeas.com for writing this article. Murphy does not own shares of any of the companies mentioned in this article. Mr. Murphy’s research firm, Murphy Analytics, may be engaged for the provision of a research report on the Company in the future.
Disclaimer/ Disclosure: The Investorideas.com is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising. Disclosure: Investorideas.com is compensated by China Direct on behalf of SUWN, averaging four thousand two hundred per week for news publication, dissemination and profile on Invesotrideas.com , its affiliate news and email sites including ir app on Running Bull http://www.investorideas.com/About/Disclaimer.asp
BC Residents and Investor Disclaimer: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894
800 665 0411